Waller R F, Keeling P J, Donald R G, Striepen B, Handman E, Lang-Unnasch N, Cowman A F, Besra G S, Roos D S, McFadden G I
Plant Cell Biology Research Centre, School of Botany, University of Melbourne, Parkville VIC 3052, Australia.
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12352-7. doi: 10.1073/pnas.95.21.12352.
A vestigial, nonphotosynthetic plastid has been identified recently in protozoan parasites of the phylum Apicomplexa. The apicomplexan plastid, or "apicoplast," is indispensable, but the complete sequence of both the Plasmodium falciparum and Toxoplasma gondii apicoplast genomes has offered no clue as to what essential metabolic function(s) this organelle might perform in parasites. To investigate possible functions of the apicoplast, we sought to identify nuclear-encoded genes whose products are targeted to the apicoplast in Plasmodium and Toxoplasma. We describe here nuclear genes encoding ribosomal proteins S9 and L28 and the fatty acid biosynthetic enzymes acyl carrier protein (ACP), beta-ketoacyl-ACP synthase III (FabH), and beta-hydroxyacyl-ACP dehydratase (FabZ). These genes show high similarity to plastid homologues, and immunolocalization of S9 and ACP verifies that the proteins accumulate in the plastid. All the putatively apicoplast-targeted proteins bear N-terminal presequences consistent with plastid targeting, and the ACP presequence is shown to be sufficient to target a recombinant green fluorescent protein reporter to the apicoplast in transgenic T. gondii. Localization of ACP, and very probably FabH and FabZ, in the apicoplast implicates fatty acid biosynthesis as a likely function of the apicoplast. Moreover, inhibition of P. falciparum growth by thiolactomycin, an inhibitor of FabH, indicates a vital role for apicoplast fatty acid biosynthesis. Because the fatty acid biosynthesis genes identified here are of a plastid/bacterial type, and distinct from those of the equivalent pathway in animals, fatty acid biosynthesis is potentially an excellent target for therapeutics directed against malaria, toxoplasmosis, and other apicomplexan-mediated diseases.
最近在顶复门的原生动物寄生虫中发现了一种退化的、非光合质体。顶复门生物的质体,即“顶质体”,是必不可少的,但恶性疟原虫和刚地弓形虫顶质体基因组的完整序列并未提供关于该细胞器在寄生虫中可能执行何种基本代谢功能的线索。为了研究顶质体的可能功能,我们试图鉴定其产物靶向疟原虫和弓形虫顶质体的核编码基因。我们在此描述了编码核糖体蛋白S9和L28以及脂肪酸生物合成酶酰基载体蛋白(ACP)、β-酮酰基-ACP合酶III(FabH)和β-羟基酰基-ACP脱水酶(FabZ)的核基因。这些基因与质体同源物高度相似,S9和ACP的免疫定位证实这些蛋白质在质体中积累。所有推测靶向顶质体的蛋白质都带有与质体靶向一致的N端前序列,并且ACP前序列被证明足以将重组绿色荧光蛋白报告基因靶向转基因弓形虫的顶质体。ACP以及很可能还有FabH和FabZ在顶质体中的定位表明脂肪酸生物合成可能是顶质体的一项功能。此外,FabH抑制剂硫乳霉素对恶性疟原虫生长的抑制作用表明顶质体脂肪酸生物合成具有至关重要的作用。由于此处鉴定出的脂肪酸生物合成基因属于质体/细菌类型,与动物中同等途径的基因不同,脂肪酸生物合成可能是针对疟疾、弓形虫病和其他由顶复门生物介导的疾病的治疗的极佳靶点。